TCI

What TCI does

TCI Co., Ltd. (大江生医) is a Taipei-headquartered, publicly listed (TPEx: 8436 since 2013) Contract Development and Manufacturing Organization (CDMO+) serving global brand owners in the health, functional nutrition, beauty, and skincare sectors. Founded in 1980 and operating 46 years, the company runs an integrated platform that spans proprietary ingredient discovery, formulation science, clinical validation, regulatory support, and large-scale manufacturing across facilities in Taiwan, mainland China, and the United States (Orem, Utah). The product portfolio combines proprietary technology platforms such as LipoMask (liposomal delivery), Synergene (formulation interaction database since 2016), TRILLION PROBIO (high-count probiotic encapsulation), Cell Young (plant stem cells), and VeCollal (vegan collagen via a Belgian partnership), alongside branded ingredients and dosage forms spanning liquid sachets, glass bottles, jelly, powder sachets, tablets, capsules, and facial masks.

The business operates on a B2B project-based CDMO revenue model with three primary streams: end-to-end CDMO services (formulation, clinical validation, manufacturing for brand owner clients), proprietary ingredient supply (e.g., VeCollal, Cell Young to brand customers), and fee-for-service R&D/formulation consulting. Pricing is quote-based per engagement, typically structured as multi-year contracts. Two horizontal customer segments are served: health and functional nutrition brands (functional foods, dietary supplements, sports nutrition, weight management) and beauty and skincare brands (cosmeceuticals, skincare, beauty supplements). Customer logos are not disclosed in the input data, but the company reports a 95% repurchase rate and serves 68+ countries with 2,700+ patents and trademarks. Recent strategic moves include the 2021 acquisition of MBI/Hekang Biotechnology for biomaterials capabilities, the 2025 transformation into a CDMO+ group with AI data-driven positioning, a November 2025 Salt Lake City research center opening focused on high-performance nutrition and regenerative medicine, and a March 2026 announcement of a US$26 million North American manufacturing expansion.

Name

TCI

Legal name

TCI Co., Ltd.

Website

https://tci-bio.com

Company type

Public

Founded year

1980

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

TCI Co., Ltd. is a Taiwan-headquartered public CDMO+ company that develops and manufactures private-label nutraceuticals and beauty products for global brand owners, operating proprietary technology platforms (LipoMask, Synergene, VeCollal) and serving 68+ countries.

Ownership category

akta.pro rank

Product category

Contract Development and Manufacturing Organization (CDMO) for Nutraceuticals and Beauty

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Contract development manufacturing
• Private label supplements
• Nutraceutical CDMO services
• Functional beverage manufacturing
• Skincare contract manufacturing

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Contract Development and Manufacturing (CDMO): Primary revenue stream from providing end-to-end CDMO services including formulation development, clinical validation, and large-scale manufacturing of nutraceuticals and skincare products for brand owner clients. Revenue generated through project fees, manufacturing fees, and ingredient supply contracts.
2. Proprietary Ingredient Supply: Sale of proprietary functional ingredients and formulations (e.g., VeCollal, Cell Young) to brand customers for incorporation into their products. Ongoing revenue from repeat ingredient supply.
3. R&D and Formulation Services: Fee-for-service scientific consulting, custom formulation development, and clinical testing services provided to brand partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

TCI is a science-driven, end-to-end CDMO+ (Contract Development and Manufacturing Organization) that develops and manufactures private-label nutraceuticals, functional beverages, and skincare/beauty products for brand owners worldwide. Its offering spans ingredient discovery, proprietary formulation platforms (LipoMask, VeCollal, Synergene, TRILLION PROBIO, Cell Young), clinical validation, regulatory support, and large-scale production across multiple dosage forms and manufacturing facilities in Asia, the US, and Europe.

Product overview

TCI is a science-driven, end-to-end CDMO+ (Contract Development and Manufacturing Organization plus) company specializing in private-label nutraceuticals and beauty products. The company offers a comprehensive portfolio spanning proprietary technology platforms (LipoMask®, Synergene®, TRILLION PROBIO, Cell Young®), branded ingredients (VeCollal® vegan collagen, Maxi Collagen™), turnkey solution series (MAXI COLLAGEN, COHERE, 4FUN, KARU, 3GEN, BOTANIST), consumer brands (AQUAGEN, Probiotic Revolution, Dr.Q), and diverse dosage forms (liquid sachets, glass bottles, jelly, powder sachets, tablets, capsules, facial masks). The company operates across Asia, North America, and Europe with 46 years of experience, serving 68+ countries with 2,700+ patents & trademarks. Key technology differentiators include doubleNUTRI ZerO 2 oxygen-free preservation, SugarLock blood glucose support, and room-temperature stable probiotics.

Differentiator

Problem solved

Functional benefit

Brands

• AQUAGEN: Sea sparkling water brand under TCI Living
• Probiotic Revolution
• Dr.Q
• VeCollal
• Maxi Collagen
• LipoMask
• Cell Young
• Green Caviar

Products and services

• CDMO Contract Development and Manufacturing Services
• Customized Solutions
• Turnkey Solutions
• LipoMask®
• VeCollal® Vegan Collagen
• Cell Young® Stem Cell Platform
• TRILLION PROBIO
• Synergene® Formulation Platform
• doubleNUTRI ZerO 2 Oxygen-Free Preservation Technology
• SugarLock Blood Glucose Support Extract
• Maxi Collagen™
• AQUAGEN Sparkling Seawater
• Probiotic Revolution (Triple Probio)
• Dr.Q Functional Snacks
• COHERE Beauty Palette
• Yummy Tummy Oatmeal
• Adaptogen Coffee (HappyBanana®)
• Condensed Lutein Drops
• TCI GENE Personalized Medicine
• MBI (Hekang Biotechnology) Natural Biomaterials

Quantifiable outcome

• Products commercialized in 67+ countries globally

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• VeCollal Partnership (Belgian Company)coreStrategic or Co-development PartnerPartnership with Belgian biotech company for VeCollal, a vegan collagen alternative technology. TCI holds distribution and manufacturing rights for this innovative animal-free collagen ingredient for supplements and beauty products.
• MBI (Molecular Biodiversity)coreStrategic or Co-development PartnerAcquisition of MBI company focused on collagen and hyaluronic acid ingredient development. Provides proprietary access to bioactive ingredients for beauty-from-within applications.
• University Research PartnersminorStrategic or Co-development PartnerCollaborative R&D partnerships with universities for clinical validation and ingredient research. Supports scientific substantiation of product claims and new technology development.

Scale indicators3 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Sirio Pharma: Sirio Pharma is a China-based CDMO specializing in nutraceuticals, functional foods, and beauty-from-within products. Directly comparable to TCI as a B2B CDMO serving brand owners globally with overlapping dosage forms (capsules, tablets, gummies, liquids) and end markets.
• Glanbia Nutritionals: Glanbia Nutritionals provides nutritional ingredients, premixes, and functional solutions to the global food, beverage, and supplement industries. Comparable to TCI as a supplier/formulator serving overlapping health-nutrition brand customers with related custom solutions capabilities.
• Vitaquest International: Vitaquest International is a US-based CDMO of nutritional supplements, functional foods, and beverages offering custom formulation and manufacturing. Directly comparable to TCI as a contract manufacturer serving health and nutrition brand clients with similar end-to-end services.
• Best Formulations: Best Formulations is a US-based contract manufacturer and packager of dietary supplements, vitamins, and nutritional products. Directly comparable to TCI as a private-label nutraceutical CDMO serving brand owners in similar tablet, capsule, powder, and liquid formats.
• Aenova: Aenova is a leading European CDMO offering solid, semi-solid, and liquid dosage forms for pharmaceuticals and nutraceuticals. Directly comparable to TCI as a CDMO serving supplement and health brand owners with similar dosage form capabilities and vertical integration.
• Robinson Pharma: Robinson Pharma is a US-based contract manufacturer specializing in private-label vitamins, supplements, and nutritional products. Directly comparable to TCI in the B2B supplement CDMO space with similar customer profiles of brand owners.

Broad incumbents

• Catalent: Catalent is a large global CDMO with broad pharma and consumer health capabilities including softgel and oral dose manufacturing. Comparable to TCI as a broad incumbent with overlapping nutraceutical CDMO services for global brand owners, though operating at much larger scale across multiple categories.
• Lonza: Lonza is a Swiss global CDMO with extensive capabilities in pharma, biologics, and consumer health/nutrition including capsules and specialty ingredients. Comparable to TCI as a broad incumbent serving similar global brand-owner customers across health and nutrition.

Others

• DSM: DSM (now DSM-Firmenich) is a global supplier of nutritional and functional ingredients including vitamins, premixes, and bioactives. Adjacent to TCI as an ingredient ecosystem participant serving the same brand-owner customers in supplements, functional food, and beauty-from-within.
• Eurofins: Eurofins is a global testing, inspection, and certification company serving food, nutraceutical, pharmaceutical, and cosmetics industries. Adjacent to TCI as a service provider to similar B2B brand-owner clients, supporting quality assurance, regulatory compliance, and product validation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@tcibiotech
• Facebookfacebook.com/tci.bio
• LinkedInlinkedin.com/company/tci-co-ltd
• Xx.com/TCIWorld

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TCI